Health
STEP 4: Significant weight loss maintained with weekly semaglutide – Healio
Adults with obesity who continued once-weekly semaglutide therapy beyond 20 weeks saw continued weight loss or weight maintenance compared with adults who were…
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected] to Healio
Adults with obesity who continued once-weekly semaglutide therapy beyond 20 weeks saw continued weight loss or weight maintenance compared with adults who were switched to placebo, data from the STEP 4 study show.
“The message here is twofold. One, for the patient and the doctor, there is hope for the medical treatment of obesity,” Domenica…
-
Noosa News17 hours agoWest Coast Eagles draftee Josh Lindsay wants to carry on Troy Selwood’s legacy
-
Noosa News21 hours agoDoorDash offering Aussies free burgers, burritos, pizzas and meal bundles as an end of year treat
-
General18 hours agoLabor to squeeze public service, sparking warnings of job losses
-
General21 hours agoSister Kate’s site to become home to Perth’s first Aboriginal aged care facility